ABMD Related Analyst Ratings

Nov 9, 2009 11:13 AM Lazard Capital Downgrades Abiomed (ABMD) to Hold

Oct 6, 2009 08:24 AM Piper Jaffray Reiterates an Overweight on ABIOMED (ABMD); Raises PT

Sep 16, 2009 09:42 AM Wedbush Morgan Upgrades Abiomed (ABMD) to Neutral; Potential Near-Term Catalysts

Jun 22, 2009 08:43 AM Piper Jaffray Maintains a 'Buy' on ABIOMED (ABMD); Raises Price Target

Apr 9, 2009 08:55 AM Piper Jaffray Initiates Coverage on ABIOMED (ABMD) with a Buy; Stock Appears Oversold

Mar 25, 2009 07:37 AM UBS Upgrades ABIOMED (ABMD) to Buy

Mar 12, 2009 08:00 AM Jefferies & Co Upgrades Abiomed (ABMD) to Hold

Feb 6, 2009 09:21 AM Morgan Stanley Downgrades ABIOMED (ABMD) to Equalweight

Feb 6, 2009 07:47 AM UBS Downgrades Abiomed (ABMD) to Neutral

Jul 29, 2008 01:04 PM SMH Capital Starts ABIOMED (ABMD) at Sell

Jun 18, 2008 09:36 AM UBS Boosts Price Target on Abiomed (ABMD) to $28

Jun 3, 2008 09:43 AM Susquehanna Downgrades ABIOMED (ABMD) to Neutral

Dec 20, 2007 08:20 AM Lehman Bros. Initiates Coverage on ABIOMED (ABMD) with an Overweight.

Dec 7, 2007 09:06 AM UBS Starts ABIOMED (ABMD) at Buy

Jun 1, 2007 07:30 AM Morgan Stanley Starts Abiomed (ABMD) at Overweight

Jun 13, 2006 02:35 PM Needham & Co Initiates Coverage on Abiomed (ABMD) with a Hold

Feb 15, 2006 09:47 AM Lazard Starts ABMD at Buy

Mar 4, 2005 10:34 AM Adams Harkness Starts ABMD at Buy